The K orean C ollege of H elicobacter and U pper G astrointestinal R esearch first
developed guidelines for the diagnosis and treatment of H elicobacter pylori (H. pylori) …

Helicobacter pylori infection is one of the most common infectious diseases worldwide.
Although the prevalence of H. pylori is gradually decreasing, approximately half of the …

Abstract The Asia–Pacific Consensus Conference was convened to review and synthesize
the most current information on Helicobacter pylori management so as to update the …

Introduction The eradication rates for Helicobacter pylori have decreased in Korea although
the prevalence of this bacterium has also decreased. Antibiotic resistance is likely to be a …

Background Antimicrobial resistance of Helicobacter pylori (H. pylori) affects the efficacy of
eradication therapy. The aim of this study was to estimate the prevalence of primary and …

OBJECTIVES: Recent treatment guidelines recommend two first-line therapies
forHelicobacter pyloriinfection: proton pump inhibitor (PPI), bismuth, tetracycline, and …

Eradication therapy for Helicobacter pylori is recommended in a number of clinical
conditions. In this article, we discuss the epidemiology and cellular mechanisms that result …

Abstract Background Antimicrobial resistance of Helicobacter pylori (H pylori) affects the
efficacy of eradication therapy. The aim of this study was to estimate the prevalence of …

Therapeutic management of Helicobacter pylori (H. pylori) remains an unsolved issue.
Indeed, no therapeutic regimen is able to cure the infection in all treated patients, and in …

Background The current prevalence of primary antibiotic resistance of H. pylori is not known
in Korea. This study was done to evaluate the prevalence of primary antibiotic resistance of …